Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats

To evaluate the optimal timing of mesenchymal stem cell (MSC) transplantation following stroke, rats were transplanted with MSCs at 1 (D1), 4 (D4), and 7 days (D7) after middle cerebral artery occlusion (MCAo). Rats in the D1 group showed a better functional recovery than those in the D4 or D7 groups after MCAo. MSCs preferentially migrated to the cortex in the D1 group, while the MSCs in the D4 or D7 groups preferentially migrated to the striatum. Interestingly, the level of monocyte chemotactic protein-1 (MCP-1) in the cortex was highest at 1 day after MCAo, while the level of stromal cell-derived factor-1 (SDF-1) in the striatum was lowest at 1 day after MCAo and then increased over time. The pattern of MCP-1 and SDF-1 level changes according to the time after MCAo was consistent with in vivo and in vitro migration patterns of MSCs. The results suggest that an earlier MSC transplantation is associated with a better functional recovery after stroke, which could be explained by the preferential migration of MSCs to the cortex in the early transplantation group. The time-dependent differential expression of MCP-1 and SDF-1 between ischemic regions seemed to mediate the differential migration of MSCs. Highest level of MCP-1 at one day of stroke may induce preferential migration of MSCs to the cortex, then better functional improvement.

[1]  M. Kameda,et al.  Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms , 2015, PloS one.

[2]  Q. Zhuge,et al.  Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke , 2014, CNS neuroscience & therapeutics.

[3]  H. Koo,et al.  Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation , 2013, Bone Marrow Transplantation.

[4]  K. Satoh,et al.  Intra-arterial Cell Transplantation Provides Timing-Dependent Cell Distribution and Functional Recovery After Stroke , 2013, Stroke.

[5]  R. Guzman,et al.  Timing of Intra-Arterial Neural Stem Cell Transplantation After Hypoxia–Ischemia Influences Cell Engraftment, Survival, and Differentiation , 2012, Stroke.

[6]  K. Reymann,et al.  Determination of the Therapeutic Time Window for Human Umbilical Cord Blood Mononuclear Cell Transplantation following Experimental Stroke in Rats , 2012, Cell transplantation.

[7]  B. Kalionis,et al.  Immunosuppressive Properties of Mesenchymal Stem Cells , 2011, Stem Cell Reviews and Reports.

[8]  Takuya Matsunaga,et al.  Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. , 2011, Brain : a journal of neurology.

[9]  Liwen Chen,et al.  Analysis of Allogenicity of Mesenchymal Stem Cells in Engraftment and Wound Healing in Mice , 2009, PloS one.

[10]  F. Locatelli,et al.  Mesenchymal stem cells for acute graft-versus-host disease – Authors' reply , 2008, The Lancet.

[11]  M. Tsubokura,et al.  Mesenchymal stem cells for acute graft-versus-host disease , 2008, The Lancet.

[12]  Guang-qian Zhou,et al.  SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model , 2008, Brain Research.

[13]  Yi Li,et al.  Therapeutic Benefit of Bone Marrow Stromal Cells Administered 1 Month after Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  M. Chopp,et al.  Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke , 2006, Neuroscience.

[15]  K. Houkin,et al.  Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. , 2006, Brain : a journal of neurology.

[16]  N. Ikeda,et al.  Novel Therapeutic Strategy for Stroke in Rats by Bone Marrow Stromal Cells and ex vivo HGF Gene Transfer with HSV-1 Vector , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  K. Houkin,et al.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat , 2006, Experimental Neurology.

[18]  N. Ikeda,et al.  Bone Marrow Stromal Cells That Enhanced Fibroblast Growth Factor-2 Secretion by Herpes Simplex Virus Vector Improve Neurological Outcome After Transient Focal Cerebral Ischemia in Rats , 2005, Stroke.

[19]  P. Sanberg,et al.  Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. , 2005, Stem cells and development.

[20]  Oh Young Bang,et al.  Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.

[21]  D. Mevorach,et al.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. , 2005, Blood.

[22]  Yi Li,et al.  Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells , 2005, Glia.

[23]  Ora Dillon-Carter,et al.  Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats , 2004, Brain Research.

[24]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[25]  M. Chopp,et al.  Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat , 2003, Journal of neuroscience research.

[26]  Yi Li,et al.  Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats , 2003, Circulation research.

[27]  M. Chopp,et al.  Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery , 2002, Neurology.

[28]  C. Culmsee,et al.  A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia , 2002, The Journal of Neuroscience.

[29]  M. Chopp,et al.  Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. , 2002, Experimental hematology.

[30]  M. Chopp,et al.  Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.

[31]  M. Chopp,et al.  Intrastriatal Transplantation of Bone Marrow Nonhematopoietic Cells Improves Functional Recovery After Stroke in Adult Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[33]  S. Constantini,et al.  An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. , 1996, Journal of neurotrauma.

[34]  K. Koike,et al.  Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. , 1996, Blood.

[35]  M Chopp,et al.  The Effect of Hypothermia on Transient Middle Cerebral Artery Occlusion in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.